Articles From: Alexandria Real Estate Equities, Inc. Announces Sale of Suburban Legacy Assets in Worcester, Massachusetts to Alexza Reports 2012 Fourth Quarter and Full Year Financial Results

Alexandria completes sales of significant income-producing assets targeted for 2013 Alexandria to reinvest proceeds into higher value, Class-A, CBD assets in Cambridge, Massachusetts PASADENA, Calif.

PASADENA, Calif.

Quarterly Cash Dividend Per Common Share Up 22% Over Past 12 Months PASADENA, Calif.

In conjunction with unprecedented gathering of senior thought leaders to advance medical research philanthropy, Alexandria releases update on its 2012 corporate responsibility achievements NEW YORK , Feb.

Alexandria Real Estate Equities, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com Canada NewsWire Company invites individual and institutional investors to log-on to view presentation NEW YORK, March 11, 2013 /CNW/ - Alexandria Real Estate Equities, Inc. (NYSE: ARE) , the largest and leading owner, operator, and developer of high-quality, sustainable real estate for the broad and diverse life science industry, is pleased to announce that its March 7th RetailInvestorConferences.com presentation is now available for on-demand viewing.

Company invites individual and institutional investors to log-on to view presentation NEW YORK , March 11, 2013 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) , the largest and leading owner, operator, and developer of high-quality, sustainable real estate for the broad and diverse life science industry, is pleased to announce that its March 7th RetailInvestorConferences.com presentation is now available for on-demand viewing.

FFO Per Share - Diluted, of $1.11, Up 3%, for the Three Months Ended 1Q13 Over 1Q12 AFFO Per Share - Diluted of $1.08, Up 6%, for the Three Months Ended 1Q13 Over 1Q12 EPS − Diluted of $0.36, Up 20%, for the Three Months Ended 1Q13 Over 1Q12 Total Revenues of $150.4 Million, Up 11%, for the Three Months Ended 1Q13 Over 1Q12 NOI from Continuing Operations of $105.2 Million, Up 10%, for the Three Months Ended 1Q13 Over 1Q12 PASADENA, Calif.

FFO Per Share - Diluted, as Adjusted, of $1.16 and $4.38 for Three Months and Year Ended 4Q12 EPS − Diluted of $0.33 and $1.09 for Three Months and Year Ended 4Q12 Total Revenues for the Three Months and Year Ended 4Q12 Up 11% and 7% Over Same Period in Prior Year NOI from Continuing Operations for the Three Months Ended 4Q12 Up 10% Over 4Q11 Achieved Significant NOI Growth From Delivery of Development and Redevelopment Projects PASADENA, Calif., Feb.

PASADENA, Calif.

PASADENA, Calif.

Alexandria Real Estate Equities, Inc. to Webcast, Live, at Virtual REIT Investor Conference - March 7th Canada NewsWire Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference NEW YORK, March 5, 2013 /CNW/ - Alexandria Real Estate Equities, Inc. (NYSE: ARE) , the largest and leading owner, operator, and developer of high-quality, sustainable real estate for the broad and diverse life science industry, is pleased to announce that Krupal Raval, Vice President of Capital Markets, will present at RetailInvestorConferences.com. DATE: March 7, 2013 TIME: 12:30 PM EST LINK: www.retailinvestorconferences.com > red "register / watch event now" button This will be a live, interactive online event where investors are invited to ask the company questions in real-time – both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event

Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference NEW YORK , March 5, 2013 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) , the largest and leading owner, operator, and developer of high-quality, sustainable real estate for the broad and diverse life science industry, is pleased to announce that Krupal Raval , Vice President of Capital Markets, will present at RetailInvestorConferences.com. DATE:  March 7, 2013 TIME:   12:30 PM EST LINK:     www.retailinvestorconferences.com > red "register / watch event now" button This will be a live, interactive online event where investors are invited to ask the company questions in real-time – both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0867019001&sourceType=1 http://www.ccnmatthews.com/logos/20111017-ALEXCO.jpg VANCOUVER, BRITISH COLUMBIA --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0872463001&sourceType=1 http://www.ccnmatthews.com/logos/20111017-ALEXCO.jpg VANCOUVER, BRITISH COLUMBIA --

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that it is broadening and strengthening its executive leadership team in line with the Company’s expanding global mission to develop and commercialize life transforming therapies for patients with disorders that are severe, life-threatening, and ultra-rare.

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) , joins the European Organization for Rare Diseases (EURORDIS), the National Organization for Rare Disorders (NORD) and patient organizations worldwide in celebrating Rare Disease Day 2013, a global effort to focus attention on rare diseases, their profound impact on patients, and the need for improved diagnosis and treatment.

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced its support of World Kidney Day 2013, a global awareness campaign led by the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations.

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2013 on Thursday, April 25, 2013 before the US financial markets open.

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the fourth quarter and year ended December 31, 2012 on Thursday, February 14, 2013 before the US financial markets open.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 1.5 million shares, or approximately 0.77%, of the outstanding Alexion common stock at a price of $90.50 per share.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results and a development pipeline update for the three months ended March 31, 2013.

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Barclays Global Healthcare Conference in Miami at 10:45 a.m. Eastern time on Tuesday, March 12, 2013.

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr.

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr.

Alexion's Soliris® (eculizumab) Receives Marketing Approval in Canada for Patients with atypical HUS Canada NewsWire First and Only Approved Treatment for atypical HUS, a Chronic and Life-Threatening Ultra-Rare Disease ONTARIO, March 6, 2013 /CNW/ - Alexion Pharma Canada ., a subsidiary of Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) , today announced that Canada's national healthcare regulatory agency, Health Canada , has approved the use of Soliris® (eculizumab) for the treatment of patients with atypical hemolytic uremic syndrome (atypical HUS) to inhibit complement-mediated thrombotic microangiopathy (TMA). Atypical HUS, or aHUS, is a life-threatening and chronic ultra-rare, genetic disease that progressively damages vital organs, leading to stroke, heart attack, kidney failure and death.

Call Scheduled Today for 9:00 a.m. Eastern Time MOUNTAIN VIEW, Calif.

MOUNTAIN VIEW, Calif.

MOUNTAIN VIEW, Calif.

MOUNTAIN VIEW, Calif.

Management to Review Results and Provide Business Updates in Conference Call Scheduled Today for 5:00 p.m. Eastern Time MOUNTAIN VIEW, Calif.